Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 12/20 | 0.61 |
| ▸ | NPBWR1 | P48145 | 3/20 | 0.58 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.56 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.55 |
| ▸ | PCSK9 | Q8NBP7 | 2/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.55 |
| ▸ | ECE1 | P42892 | 1/20 | 0.55 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30633324 | 0.94 | NPBWR1 (0.64) | GLP1RNPBWR1RXFP1 | |
| SCHEMBL10537009 | 0.88 | MAGI3 (0.61) | GLP1RNPBWR1PCSK9RXFP1ECE1 | |
| SCHEMBL31467396 | 0.88 | KISS1R (0.62) | GLP1RNPBWR1KISS1RPCSK9 | |
| SCHEMBL29983511 | 0.88 | GLP1R (0.62) | GLP1RKEAP1RXFP1ECE1MUS81 | |
| SCHEMBL31099263 | 0.87 | GLP1R (0.63) | GLP1RNPBWR1RXFP1ECE1MUS81 | |
| SCHEMBL29634675 | 0.87 | GLP1R (0.63) | GLP1RNPBWR1RXFP1ECE1MUS81 | |
| SCHEMBL30906492 | 0.86 | GLP1R (0.70) | GLP1RRXFP1ECE1MUS81 | |
| SCHEMBL31087271 | 0.86 | RXFP1 (0.68) | GLP1RNPBWR1RXFP1ECE1MUS81 | |
| SCHEMBL30271994 | 0.86 | RXFP1 (0.68) | GLP1RNPBWR1RXFP1ECE1MUS81 | |
| SCHEMBL31759108 | 0.86 | RXFP1 (0.67) | GLP1RNPBWR1KEAP1RXFP1ECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12428447-B2 | Peptide-based non-proteinaceous cargo delivery | FELDAN BIO INC. (CA) | 2025-09-30 | — | — | US | disclosed |
| EP-4556567-A2 | RATIONALLY-DESIGNED SYNTHETIC PEPTIDE SHUTTLE AGENTS FOR DELIVERING POLYPEPTIDE CARGOS FROM AN EXTRACELLULAR SPACE TO THE CYTOSOL AND/OR NUCLEUS OF A TARGET EUKARYOTIC CELL, USES THEREOF, METHODS AND KITS RELATING TO SAME | Feldan Bio Inc. (CA) | 2025-05-21 | — | — | EP | disclosed |
| US-12286632-B2 | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same | FELDAN BIO INC. (CA) | 2025-04-29 | — | — | US | disclosed |
| US-12144910-B2 | Methods of coating antimicrobial peptides on the biomaterial and the biomaterial coated thereby | ACADEMIA SINICA (TW) | 2024-11-19 | — | — | US | disclosed |
| US-12060387-B2 | Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same | FELDAN BIO INC. (CA) | 2024-08-13 | — | — | US | disclosed |
| US-20230399661-A1 | SHUTTLE AGENT PEPTIDES OF MINIMAL LENGTH AND VARIANTS THEREOF ADAPTED FOR TRANSDUCTION OF CAS9-RNP AND OTHER NUCLEOPROTEIN CARGOS | FELDAN BIO INC. (CA) | 2023-12-14 | — | — | US | disclosed |
| US-20230383291-A1 | PEPTIDE-BASED TRANSDUCTION OF NON-ANIONIC POLYNUCLEOTIDE ANALOGS FOR GENE EXPRESSION MODULATION | FELDAN BIO INC. (CA) | 2023-11-30 | — | — | US | disclosed |
| US-20230348537-A1 | RATIONALLY-DESIGNED SYNTHETIC PEPTIDE SHUTTLE AGENTS FOR DELIVERING POLYPEPTIDE CARGOS FROM AN EXTRACELLULAR SPACE TO THE CYTOSOL AND/OR NUCLEUS OF A TARGET EUKARYOTIC CELL, USES THEREOF, METHODS AND KITS RELATING TO SAME | FELDAN BIO INC. (CA) | 2023-11-02 | — | — | US | disclosed |
| EP-4232590-A1 | SHUTTLE AGENT PEPTIDES OF MINIMAL LENGTH AND VARIANTS THEREOF ADAPTED FOR TRANSDUCTION OF CAS9-RNP AND OTHER NUCLEOPROTEIN CARGOS | Feldan Bio Inc. (CA) | 2023-08-30 | — | — | EP | disclosed |
| EP-4229207-A1 | PEPTIDE-BASED TRANSDUCTION OF NON-ANIONIC POLYNUCLEOTIDE ANALOGS FOR GENE EXPRESSION MODULATION | Feldan Bio Inc. (CA) | 2023-08-23 | — | — | EP | disclosed |
| US-11629170-B2 | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same | FELDAN BIO INC. (CA) | 2023-04-18 | — | — | US | disclosed |
| US-20220226545-A1 | METHODS OF COATING ANTIMICROBIAL PEPTIDES ON THE BIOMATERIAL AND THE BIOMATERIAL COATED THEREBY | ACADEMIA SINICA (TW) | 2022-07-21 | — | — | US | disclosed |
| US-20220204561-A1 | PEPTIDE-BASED NON-PROTEINACEOUS CARGO DELIVERY | FELDAN BIO INC. (CA) | 2022-06-30 | — | — | US | disclosed |
| WO-2022082315-A1 | SHUTTLE AGENT PEPTIDES OF MINIMAL LENGH AND VARIANTS THEREOF ADAPTED FOR TRANSDUCTION OF CAS9-RNP AND OTHER NUCLEOPROTEIN CARGOS | FELDAN BIO INC. (CA) | 2022-04-28 | — | — | WO | disclosed |
| WO-2022077121-A1 | PEPTIDE-BASED TRANSDUCTION OF NON-ANIONIC POLYNUCLEOTIDE ANALOGS FOR GENE EXPRESSION MODULATION | FELDAN BIO INC. (CA) | 2022-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12286632-B2 | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same | KPNA6, KPNA1, KPNA2 | GLP1R 3100/4885NPBWR1 1857/4885KEAP1 1516/4885 |
| US-11629170-B2 | Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same | KPNA6, KPNA1, KPNA2 | GLP1R 3100/4885NPBWR1 1857/4885KEAP1 1516/4885 |
| US-20230348537-A1 | RATIONALLY-DESIGNED SYNTHETIC PEPTIDE SHUTTLE AGENTS FOR DELIVERING POLYPEPTIDE CARGOS FROM AN EXTRACELLULAR SPACE TO THE CYTOSOL AND/OR NUCLEUS OF A TARGET EUKARYOTIC CELL, USES THEREOF, METHODS AND KITS RELATING TO SAME | KPNA6, KPNA1, KPNA2 | GLP1R 3100/4885NPBWR1 1857/4885KEAP1 1516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.